𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evidence for GABAergic inhibitory deficits in major depressive disorder

✍ Scribed by Paul E. Croarkin; Andrea J. Levinson; Zafiris J. Daskalakis


Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
268 KB
Volume
35
Category
Article
ISSN
0149-7634

No coin nor oath required. For personal study only.

✦ Synopsis


Converging evidence suggests that deficits in gamma-aminobutyric acid (GABA) functioning are implicated in the pathophysiology of major depressive disorder (MDD). This is highlighted by research investigating cortical inhibition (CI), a process whereby GABAergic interneurons selectively attenuate pyramidal neurons. Transcranial magnetic stimulation (TMS) paradigms evaluate this marker of neuronal inhibitory activity in the cortex. This review will examine the neuroanatomic and neurophysiological evidence from neuroimaging, molecular, treatment, and TMS studies linking dysfunctional GABAergic neurotransmission to MDD.


πŸ“œ SIMILAR VOLUMES


Use of health services for major depress
✍ J. HΓ€mΓ€lΓ€inen; E. IsometsΓ€; S. Sihvo; S. Pirkola; O. Kiviruusu πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 1 views

Factors associated with people suffering from major depressive disorder (MDD) or anxiety disorders seeking or receiving treatment are not well known. In the Health 2000 Study, a representative sample (n=6005) of Finland's general adult (> or =30 years) population was interviewed with the M-CIDI for